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Abstract. Nowadays, several databases store information about patients and dis-
eases, but only a few exists that focus directly on myocardial events and treatments.
This paper is divided into two parts. In the ﬁrst part, we list and summarize the on-
going European myocardial projects (Myocardial Ischaemia National Audit Project
(MINAP) in England, Swedish Web-system for Enhancement and Development of
Evidence-based care in Heart disease Evaluated According to Recommended Ther-
apies (SWEDEHEART) in Sweden, National Registry of Acute Myocardial Infarc-
tion in Switzerland (AMIS Plus) in Switzerland). Where possible, we discuss the
validity and accuracy of the stored data. In the second part, we introduce the history
and legal environment of the Hungarian Myocardial Infarction Registry (HUMIR),
and some research results that were achieved with the help of the information in
the Hungarian registry.
Keywords. ACS, Infarction registry, Myocardial infarction, Hungarian Myocardial
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1. Introduction
In the recent decades a decline is seen in coronary heart disease mortality [1]. Researches
found that there is a difference in the decline based on the socioeconomic background
of the patients [2][3]. For instance, the group of less educated people shows a smaller
decrement. On one hand, the decline in coronary heart disease mortality can be one of
the major signiﬁcance of public health and a result of the new methods of treatment. On
the other hand, more accurate and more complete information is needed to conﬁrm such
statements – because cardiovascular disease continues to be one of the most common
cause of death in both men and women.
US surgeon Dr. Ernest Amory Codman said: ”Every hospital should follow every
patient it treats long enough to determine whether or not the treatment was successful
and to inquire ‘if not, why not?’ with a view to preventing similar failures in future.” [4]
Nowadays, most of the countries have their own mortality and disease statistics
based on International Classiﬁcation of Diseases – however, these statistics never con-
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tain clinical informations, for example results of former examinations, comorbidity or
smoking behavior of the patients.
Today only a few system exists that focuses directly on myocardial events and treat-
ments. The common vision behind such registries is the more speciﬁc the information
we collect, the better quality control we can have. Thus, the quality of the treatment and
then the prognosis of the patients improve.
First, the paper lists and summarizes three ongoing European myocardial projects:
Myocardial Ischaemia National Audit Project (MINAP) in England, Swedish Web-
system for Enhancement and Development of Evidence-based care in Heart disease Eval-
uated According to Recommended Therapies (SWEDEHEART) and National Registry
of Acute Myocardial Infarction in Switzerland (AMIS Plus). Then the authors introduce
the history and legal environment of the Hungarian Myocardial Infarction Registry (HU-
MIR). Where possible, the authors discuss the validity and accuracy of the registers and
some results based on them. Finally, some conclusive remarks are provided.
2. Existing myocardial infarction registers
In this section, we list three ongoing European myocardial projects.
2.1. Myocardial Ischaemia National Audit Project
The Myocardial Ischaemia National Audit Project is a national clinical audit of the man-
agement of heart attack in England, Wales and Northern Ireland. It is one of six national
cardiac clinical audits that are managed by the National Institute for Cardiovascular Out-
comes Research (NICOR), which is part of the Institute for Cardiovascular Science at
University College London. MINAP was established in 1999 and data collection began
in October 2000.
The aims of MINAP: to audit the quality of care of patients with acute coronary
syndrome (ACS) and provide a resource for academic research [6].
Based on the 2015 Annual Report [5] 217 acute hospitals in England, Wales and
Northern Ireland participate in the project and continuously send the encrypted data of
130 ﬁelds covering demographic factors, co-morbid conditions and treatment speciﬁca-
tions in hospital.
80% of hospitals use MINAP software to enter the data into the system and the
rest of the hospitals use a locally developed software or commercial applications for this
purpose.
The data itself is available for research by application to NICOR.
2.2. Swedish Web-system for Enhancement and Development of Evidence-based care in
Heart disease Evaluated According to Recommended Therapies (SWEDEHEART)
SWEDEHEART was launched in 2009 after merging four Swedish national registries on
coronary artery disease. The project is supported by the Swedish Society of Cardiology,
the Swedish Society of Thoracic Radiology, the Swedish Society of Thoracic Surgery,
and the Swedish Heart Association. The registry is ﬁnanced by the Swedish Associa-
tion of Local Authorities and Regions, the Swedish state, and the Swedish Heart-Lung
Foundation [8].
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The primary purpose of SWEDEHEART is to support development of evidence-
based therapies in acute and chronic coronary artery disease and in catheter-based or
surgical valve intervention by providing continuous information on patient care needs,
treatments, and treatment outcomes.
The number of participating Swedish hospitals is 74 in 2016, corresponding to 95%
degree of coverage at hospital level. About the data ﬁelds [9]:
1. 106 variables for patients with ACS,
2. 75 variables regarding secondary prevention after 12-24 months,
3. 150 variables for patients undergoing coronary angiography/angioplasty and
4. 100 variables for patients undergoing heart surgery.
All data are registered on a web-based interface directly by the caregiver. The data
itself is available for research by application to the SWEDEHEART steering group.
2.3. National Registry of Acute Myocardial Infarction in Switzerland (AMIS Plus)
The Swiss registry of acute coronary syndrome is called National Registry of Acute
Myocardial Infarction in Switzerland (AMIS Plus). In the list of the aims of the registry,
we ﬁnd:
1. to understand the transfer, use and practicability of knowledge gained from ran-
domised trials
2. to generate input for subsequent prospective and randomised studies.
3. to determine how adherence to guideline-based treatments in the ”real world”
works.
The AMIS Project was initiated in 1997 [10]. AMIS Plus has been continuously col-
lecting data since then on patients admitted to Swiss hospitals with acute coronary syn-
dromes. Today it operates as an industry-sponsored project. The treating doctor or trained
study nurse enter the information online or through a paper-based questionnaire. Out of
106 hospitals treating ACS in Switzerland, 76 hospitals temporarily or continuously send
data into the registry (coverage of 72%).
The data itself is available for research with the approval of the AMIS Plus Steering
Committee.
2.4. Auditing & Quality of data
One of the key questions about this large amount of data is its accuracy. All of the regis-
ters use solutions based on some kind of randomisation technique to check and improve
the quality.
MINAP has a specially designed data validation tool. Every year, the system re-
quires every hospital to re-enter 20 data items from the medical records of 20 randomly
selected patients [6]. Then, this re-entered data gets compared with the original ones and
an agreement score is generated to every hospital. At the end of the process, the hospitals
get their scores with advices how to improve performance. The median level of agree-
ment between MINAP data and re-audit data (across all hospitals) was 72% in 2003 and
has risen to 89.5% in 2008 [7].
SWEDEHEART uses personal validation solution. A monitor visits approximately
20 hospitals every year. In 2007, accuracy of 96% was reported [9].
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AMIS Plus also uses random selection for auditing. Two large and three small hos-
pitals, and about 5-10 patients are randomly selected each year. A summary from 2014
[11] reports there were 0.05% critical, another 0.05% major, and 2.2% minor ﬁndings.
3. Hungarian Myocardial Infarction Registry (HUMIR)
In this section, we introduce the Hungarian registry; review the changing of the legal
environment; show the completeness and validity, and, ﬁnally, overview some research
results that were obtained using the data collected.
3.1. History
In the 1970s, World Health Organization (WHO) started a global investigation on acute
myocardial infarction registries [12]. Hungary participated in the project with the South
Pest Myocardial Infarction Registry [13], which was a paper-based system covering all
patients who had acute myocardial infarction (AMI) in six districts of Budapest (affected
373 269 inhabitants [14]). The program made it possible to measure the incidence rates
of AMI and the pre-hospital, in-hospital and 1-year mortality rates [15].
Based on the monitoring system, a new patient care system called Myocardial In-
farction Patients’ Care in CCU also started. The results were published almost a decade
later [16]. The improvement on survival is signiﬁcant, as shown in Table 1.
Table 1.: Mortality rates in 1971 and 1979 in South Pest
Results - 1971 Results - 1979
Admitted to Coronary Care Unit 7,8% 57,1%
Pre-hospital mortality 30,5% 25,1%
28-day-mortality - Pre- and in-hospital cases 51,7% 41,5%
In the next decades the diagnostic criterias, the clinical forms, and the optimal care
strategies have signiﬁcantly changed the physicians’ knowledge about AMI. In addition,
physicians faced some other challenges as well:
1. the current International Statistical Classiﬁcation of Diseases and Related Health
Problems (ICD-10) does not separate the two clinical forms of AMI: ST-segment
(STEMI) and Non–ST-segment elevation myocardial infarction (NSTEMI)
2. therefore, the hospital and ﬁnance databases are not capable to investigate the
treatment of AMI
3. the frequency of catheter-directed therapy of STEMI is not known
4. the 28-day and 1-year mortality information is not available
5. the frequency of drugs in the secundary prevention is also not known
As a consequence of the all these deﬁciencies, a need for a new infarction registry
system arose. In January 1, 2010, a web-based system was introduced to collect AMI
information from ﬁve districts of Budapest and the county of Szabolcs-Szatma´r-Bereg
[17].
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3.2. Legal background
Until 2013, the transfer of the data was voluntary for the hospitals and was based on
the patients’ full, written informed consent. In Januar 1, 2014 a new legal environment
changed this situation. As Hungarian Gazette writes [18], ”Diagnosing a myocardial
infarction, the patient care doctor is forwarding the patient’s identity and healthcare data,
concerning the myocardial infarction, to the National Registry of Myocardial Infarction”.
Table 2 summaries the essential stages of the Hungarian registry.
Table 2.: Essential stages of the Hungarian Myocardial Infarction Registry
Stage Data transfer Date
Research plan 08.07.01 - 09.12.31
IR Pilot Investigation voluntary 10.01.01 - 11.12.31
HUMIR voluntary 12.01.01 - 13.02.28
HUMIR obligatory 13.03.01 - 13.12.31
HUMIR legal regulations 14.01.01 - present
At April of 2017, the 91 participating hospitals reported 72 281 cases with 67 486 pa-
tients.
3.3. Changing of completeness and validity of data in HUMIR from 2011 to 2016
Table 3 contains the number of patients registered in HUMIR and the completeness of the
stored data. Completeness is a ratio and calculated on the proportion of two numbers: the
numbers of patients treated with AMI originated from National Health Insurance Fund
of Hungary (the central ofﬁcial organ of health insurance, supervised by the Government
of Hungary; Hungarian acronym: OEP); and the numbers of patients in HUMIR.
Table 3.: Completeness of the registered data in HUMIR
Year Nr. of Patients (HUMIR) Completeness of data (HUMIR)
2010 2407 below 30% (voluntary period)
2011 6877 below 30% (voluntary period)
2012 7550 appr. 30% (voluntary period)
2013 7828 51%
2014 10458 67%
2015 12536 82%
2016 13843 83,9%
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3.4. Researches and results based on HUMIR
In the last few years, the data of HUMIR has been used in several researches to extract
new results. Here we list a few examples.
A research reported that between 1st of January 2010 and 1st of May 2011 4293
patients were registered, among them 52.1% with STEMI, 42.1% with NSTEMI, while
3% of the patients had unstable angina (a type of acute coronary syndrome), and 2.8%
of the cases had other diagnosis or the hospital diagnosis was missing [19].
In the year of 2010 and 2011, 4981 patients (3038 men) were included in the
database. The target of the research [20] was to compare the clinical data and progno-
sis of patients with STEMI in that years. Women were signiﬁcantly older (67.7±13.5
vs. 60.5±12.5 years; p<0.001). Hypertension, diabetes, and stroke were more frequent
among women, whereas smoking and previous myocardial infarction were found more
often among men. Percutaneous coronary intervention was signiﬁcantly more frequently
performed in men than in women (82.4% vs. 75.3%; p<0.001).
Based on the data of 8582 myocardial infarction patients (4981 with STEMI), a
research found that the hospital, 30-day and 1-year mortality of patients with STEMI
were 3.7%, 9.5% and 16.5%, respectively. In patients with NSTEMI these ﬁgures were
4%, 9.8% and 21.7%, respectively [21].
Another research based on information stored in HUMIR found that the mean age of
STEMI patients was lower by 5.3 years than that of patients treated for NSTEMI. In the
group of NSTEMI patients, the occurrence of diabetes, hypertension, peripheral vascular
disease, and previous history of myocardial infarction and stroke were signiﬁcantly more
frequent. The in-hospital mortality rate of STEMI patients was 3.7%, and 30-day and
1-year mortality rates were 9.5 and 16.5%, respectively [22].
For 10 000 residents the incidence of myocardial infarction in Budapest was 28.63 in
males and 16.21 in females, while in Szabolcs-Szatma´r-Bereg county the mean incidence
was 32.49 for males and 18.59 for females [23].
A research compared casemix, treatments and outcome for STEMI patients who are
treated in Hungary or Sweden [24]. The Swedish data source was the SWEDEHEART
registry. There were substantial differences in baseline characteristics between the two
countries, with the Hungarian STEMI patients being younger and having more cardio-
vascular risk factors. More patients in Sweden received thrombolysis (5.4% versus 1.5%)
or underwent primary PCI/subsequent coronary angiogram (91.2% versus 84.2%). The
30-day mortality was lower in Sweden than in Hungary (7.9% versus 9.5%; odds ratio
0.81, 95% conﬁdence interval 0.72 to 0.93).
The aim of authors of another research was to obtain data on the signiﬁcance of
the culprit vessel in patients with STEMI treated successfully by primary percutaneous
coronary intervention [25]. The culprit vessels were the left main artery, left anterior de-
scendent artery, left circumﬂex artery, and right coronary artery. The majority of the cul-
prit lesions were found in the left anterior descendent artery (44.3%), the right coronary
artery (40.9%), and the left circumﬂex artery (13.7%). The culprit vessel was overall a
highly signiﬁcant (p<0.0001) factor of survival.
In a research [26], the frequency of the real-life usage of coronary intervention, its
long-term efﬁcacy and safety in elderly patients with AMI were investigated. A total of
8485 consecutive patients were enrolled; 65% of the patients were male (mean age was
65.1 ± 12.4); and 51% of all cases was STEMI. As a conclusion, the authors state that
coronary intervention is underused among the elderly despite the mortality beneﬁt.
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In 2015, 12 681 patients had 12 941 acute myocardial infarctions. A research [27] in
2017 found that less than half of patients (44.4%) were treated with STEMI. 91.6% of the
patients were treated in hospital with invasive facilities. Most of the patients (94%) with
positive coronary arteriography were treated with percutaneous coronary intervention.
The 30 day mortality of the whole group was 12.8% vs. 8.6% of patients treated with an
invasive procedure.
4. Data mining in cardiology
Early predication using data mining and ECG signal analysis has been proven to be
effective in predicting from the feature analysis of these signals myocardial infractions.
These have evidently investigated and reported in scientiﬁc journals.
For example [28] could predict earlier prediction of heart attack from the non-linear
analysis of heart rate variability features.
Deep learning also is used in [29] to provide automated detection of Arrhythmias
based on different intervals of Tachycardia ECG. The reported analysis in [29] shows
high prediction and accuracy in such analysis.
The classiﬁcation for myocardial infarction registries could be automated based on
characterization of myocardial infarction by decomposition of ECG signals [30] that
can be enhanced using deep learning for automated detection of myocardial infarction
[31][32].
Some characteristics of heart congestion using signal analysis of myocardial infarc-
tion, and congestive heart failure could provide better automation as reported in [33].
5. Summary and Conclusion
We summarized the ongoing European myocardial registry projects in England, Swe-
den, Switzerland and Hungary. Then the details of the Hungarian Myocardial Infarction
Registry was introduced: its history, legal environment and the changing value of com-
pleteness of the stored data. Some research results were quoted to demonstrate the us-
ing of information stored in the hungarian system. Finally, recent researches and results
connected to myocardial infractions and registries were discussed.
As Dr. Ernest Amory Codman said, every hospital should follow every patient to
prevent the recurring failures in future. Today only a few country recognized that – in
the case of infarction – myocardial registries are the most accurate way to follow every
patient.
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